Moore, Raeanne C.; Chattillion, Elizabeth A.; Ceglowski, Jennifer; Ho, Jennifer; von Känel, Roland; Mills, Paul J.; Ziegler, Michael G.; Patterson, Thomas L.; Grant, Igor; Mausbach, Brent T. (2013). A randomized clinical trial of Behavioral Activation (BA) therapy for improving psychological and physical health in dementia caregivers: results of the Pleasant Events Program (PEP). Behaviour research and therapy, 51(10), pp. 623-632. Elsevier 10.1016/j.brat.2013.07.005
Text
Behav_Res_Ther_2013.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (475kB) |
Dementia caregiving is associated with elevations in depressive symptoms and increased risk for cardiovascular diseases (CVD). This study evaluated the efficacy of the Pleasant Events Program (PEP), a 6-week Behavioral Activation intervention designed to reduce CVD risk and depressive symptoms in caregivers. One hundred dementia family caregivers were randomized to either the 6-week PEP intervention (N = 49) or a time-equivalent Information-Support (IS) control condition (N = 51). Assessments were completed pre- and post-intervention and at 1-year follow-up. Biological assessments included CVD risk markers Interleukin-6 (IL-6) and D-dimer. Psychosocial outcomes included depressive symptoms, positive affect, and negative affect. Participants receiving the PEP intervention had significantly greater reductions in IL-6 (p = .040), depressive symptoms (p = .039), and negative affect (p = .021) from pre- to post-treatment. For IL-6, clinically significant improvement was observed in 20.0% of PEP participants and 6.5% of IS participants. For depressive symptoms, clinically significant improvement was found for 32.7% of PEP vs 11.8% of IS participants. Group differences in change from baseline to 1-year follow-up were non-significant for all outcomes. The PEP program decreased depression and improved a measure of physiological health in older dementia caregivers. Future research should examine the efficacy of PEP for improving other CVD biomarkers and seek to sustain the intervention's effects.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology > Centre of Competence for Psychosomatic Medicine |
UniBE Contributor: |
von Känel, Roland |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0005-7967 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Annette Barbara Kocher |
Date Deposited: |
13 Jun 2014 12:11 |
Last Modified: |
05 Dec 2022 14:31 |
Publisher DOI: |
10.1016/j.brat.2013.07.005 |
PubMed ID: |
23916631 |
Uncontrolled Keywords: |
Alzheimer's disease, Cardiovascular disease, Depression, Intervention, Treatment |
BORIS DOI: |
10.7892/boris.47256 |
URI: |
https://boris.unibe.ch/id/eprint/47256 |